Conjugatable ligands are designed to enhance the immune response by targeting specific receptors or pathways. They are chemically modified to allow attachment to a peptide or protein using a chemical linker, thereby enhancing stability, bioavailability, and targeting precision. Conjugatable ligands mainly include cytosolic pattern recognition receptors (PRRs), C-type lectin receptors (CLRs), Toll-like receptors (TLRs), PRR agonists, and toxoid adjuvants. Developing conjugatable ligands that target various immune receptors is essential for effective targeted therapies and vaccine delivery systems.
Product Name | Catalog | Unit Size | Price |
---|---|---|---|
3A-MPLA | CDAD24-107-T | 1 mg | INQUIRY |
3D-MPLA | CDAD24-108-T | 10 mg | INQUIRY |
3M-011 | CDAD24-126-T | 50 mg, 100 mg, 250 mg | INQUIRY |
4A-MPLA | CDAD24-109-T | 1 mg | INQUIRY |
AT type Non-CpG ODN-1 (Lactobacillus gasseri) | CDAD24-086-T | 100 µg | INQUIRY |
AT type Non-CpG ODN-2 (Lactobacillus gasseri) | CDAD24-087-T | 100 µg | INQUIRY |
AT type Non-CpG ODN-3 (Malaria) | CDAD24-088-T | 100 µg | INQUIRY |
AXC-715 hydrochloride | CDAD24-127-T | 50 mg, 100 mg, 250 mg | INQUIRY |
BBIQ | CDAD24-125-T | 5 mg, 10 mg, 25 mg | INQUIRY |
Colistin adjuvant | CDAD24-142-T | 50 mg, 100 mg, 250 mg | INQUIRY |
Core-iODN | CDAD24-084-T | 100 µg | INQUIRY |
CRX-601 | CDAD24-117-T | 1 mg, 5 mg, 10 mg | INQUIRY |
Diphosphoryl Lipid A (E. coli K12 D31m4) | CDAD24-113-T | 1 mg | INQUIRY |
Diprovocim | CDAD24-089-T | 5 mg, 10 mg, 25 mg | INQUIRY |
Diprovocim-X | CDAD24-096-T | 1 mg, 5 mg, 10 mg | INQUIRY |
FP11 | CDAD24-110-T | 1 g | INQUIRY |
FP18 | CDAD24-111-T | 5 mg, 10 mg | INQUIRY |
FP20 | CDAD24-112-T | 5 mg, 10 mg | INQUIRY |
FSL-1 | CDAD24-101-T | 1 mg, 5 mg | INQUIRY |
G-ODN Murine | CDAD24-082-T | 200 µg | INQUIRY |